基础医学与临床 ›› 2014, Vol. 34 ›› Issue (11): 1578-1581.
• 短篇综述 • 上一篇 下一篇
唐旭1,苟兴春2
收稿日期:
修回日期:
出版日期:
发布日期:
通讯作者:
Received:
Revised:
Online:
Published:
Contact:
摘要： mTOR信号通路高表达于肝癌并参与其多种恶性生物学行为，是治疗的潜在靶点，但单一使用mTOR抑制剂能抑制免疫功能，并反馈性激活mTOR上游分子Akt诱导抵抗。mTOR抑制剂联合其他药物能通过协同效应克服上述不足，是抗肝癌治疗的新策略。
关键词: 肝癌, mTOR, 靶向治疗
Abstract: Aberrant mammalian target of rapamycin (mTOR) signaling has a critical role in the pathogenesis of hepatocellular carcinoma (HCC) and is a potential target. The effects of mTOR inhibitors used as single agent on HCC are limited due to immunosuppression and resistance induced by paradoxical activation of Akt. Combined use of mTOR inhibitors and other anticancer agents synergistically improves the therapy for HCC, and may be a promising therapeutic strategy.
Key words: hepatocellular carcinoma, mTOR, targeting
中图分类号:
R735.7
唐旭 苟兴春. 基于mTOR信号通路的靶向抗肝癌研究进展[J]. 基础医学与临床, 2014, 34(11): 1578-1581.
0 / / 推荐
导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks
链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/
http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2014/V34/I11/1578
